ABSTRACT Broiler hens consuming feed to appetite (ad libitum; AL) show increased mortality. Feed restriction (R) typically improves reproductive performance and livability of hens. Rapidly growing broilers can exhibit increased mortality due to cardiac insufficiency but it is unknown whether the increased mortality of non-R broiler hens is also due to cardiac compromise. To assess cardiac growth and physiology in fully mature birds, 45-week-old hens were either continued on R rations or assigned to AL feeding for 7 or 21 days. AL hens exhibited increased bodyweight, adiposity, absolute and relative heart weight, ventricular hypertrophy, and cardiac protein/DNA ratio by d 21 (P < 0.05). Increased heart weights due to hypertrophic growth was attributed to enhanced IGF-1-Akt-FoxO1 signaling and its downstream target, translation initiation factor 4E-BP1 in conjunction with down-regulation of ubiquitin ligase atrogin-1/MAFbx (P < 0.05). Reduced activation of cardiac AMPK and downstream activation of ACC-1 in parallel with increased cardiac nitric oxide levels, calcineurin activity, and MAPK activation in AL hens (P < 0.05) suggested that metabolic derangement develops along the cardiovascular remodeling. These indictors of cardiac maladaptive hypertrophic growth were further supported by uregulation of heart failure markers, BNP and MHC-β (P < 0.05). Hens allowed AL feeding for 70 d exhibited a higher incidence of mortality (40% vs. 10%) in association with ascites, pericardial effusion, and ventricle dilation. A higher incidence of irregular ECG patterns and rhythmicity consistent with persistently elevated systolic blood pressure and ventricle fibrosis were observed in AL hens (P < 0.05). These observations support the conclusion that AL feeding in broiler hens results in maladaptive cardiac hypertrophy that progresses to overt pathogenesis in contractility and thereby increases mortality. Feed restriction provides clear physiological benefit to heart function of adult broiler hens.
INTRODUCTION
Due to intensive genetic selection for early rapid growth, modern strains of broiler are prone to sudden death and a higher incidence of metabolic disorders such as ascites, fatty liver, and obesity, and co- 3 Chung-Yu Chen, Hsuan-Yu Lin, These authors contributed equally to this work. 4 Correspondeing author: shueneic@dragon.nchu.edu.tw All authors listed have contributed to the work and have agreed to submit the manuscript to Poultry Science. No part of the work has been published before, except in abstract form, and all human and animal studies have been reviewed by the appropriate ethics committees. morbid conditions including poor reproductive performance (Griffin and Goddard, 1994; McGovern et al., 1999; Julian, 2000) . These undesirable outcomes have been ascribed to dysregulation of appetite coincident to genetic selection for rapid early growth (Richards and Proszkowiec-Weglarz, 2007) . Broilers consuming feed to appetite appear to be in excess of requirements for optimal adult health and performance; both livability and reproductive performance are improved by restricting feed intake (Griffin and Goddard, 1994; Chen et al., 2006 .
Most studies regarding cardiomyopathy in broilers have been focused on ascites (also called pulmonary hypertension syndrome) in young growing birds, which is characterized by an excessive accumulation of transudate fluid in the abdominal cavity and clinical diagnosis of hypoxaemia, work overload of the cardiopulmonary system, hypertrophy of the right ventricle, and a higher incidence of sudden death (Julian, 2000 , Wideman et al., 2013 . The disorder is etiologically attributed to imbalances between cardiac output and the pulmonary vascular capacity.
To date, very few studies have sought to delineate the relationships between pathogenesis of metabolic dysfunction due to unrestricted feed intake and premature death in adult broilers. To lower mortality of the birds, a better understanding is needed to develop improved management strategies that provide the benefits of feed restriction with regards to production and livability while minimizing undue hunger that may accompany this management technique.
We previously characterized obesity-associated lipotoxic manifestations in ad libitum (AL) fed hens including systemic inflammation, aberrant leukocyte functions, and ovarian granulosa cell death leading to ovarian follicle regression in broiler hens as well as other meat-type country chickens (Chen et al., 2006; Pan et al., 2012; Xie et al., 2012; Liu et al., 2014; Walzem and Chen, 2014; 2016) . In mammals, it is known that obesity and related metabolic disturbances can compromise heart function despite the heart's drawing 70% of its energetic needs from fatty acids (Calvani et al., 2000) . We hypothesized that similar dysfunctions could occur in the hearts of AL broiler hens. Finding no information in the literature on this topic we undertook a series of studies to characterize molecular, biochemical, structural, and functional changes in the hearts of broiler hens consuming feed to appetite in comparison to those fed to achieve commercial feed restriction recommendations.
MATERIALS AND METHODS

Animal Management
A flock of Arbor Acres Plus FF (Fast Feathering) broiler breeder hens, 23 wk old with an average weight of 2.8 kg, was purchased from a local breeder farm. Hens were caged individually and raised to age of 45 wk using breeder company recommendations for feed to achieve a targeted body weight (3.6 kg) and to avoid rapid compensatory growth in frame size (skeletal and muscular growth) upon release from restricted feeding. Feed amounts were adjusted weekly to provide a nutritionally adequate soy-and corn-based breeder mash (Supple . Table S1 ). All birds were maintained on a photoschedule 14L:10D (lights on at 05:00 AM) with feed provided at 08:30AM and free access to water throughout the experiment. At age 45 wk, 15 birds were continued per breeder recommended ration restrictions (restricted group, R) while another 15 birds were provided with sufficient feed for consumption to appetite (unrestricted group, ad libitum, AL) for 3 weeks. Another 20 R hens at the age of 49 wk were either continued on recommended feed allocation or allowed AL feed intake for 10 wk (n = 10 for each) to examine the mortality, blood pressure (BP), electrocardiography (ECG), and long-term change in heart structure after 21 d and 70 d feeding treatment. All bird husbandry, tissue collections, and bird numbers used for cardiac pathogenesis and survival feeding trial were conducted in accordance with an approved animal care protocol by the Institutional Animal Care and Use Committee (IACUC) of National Chung Hsing University, Taiwan.
Necropsy and Tissue Collection
At age 46 and 48 wk (7 d and 21 d after feeding treatment), tissues were collected from 3 and 12 hens, respectively, from each treatment group following an overnight fast. Prior to tissue collection, birds were physically restrained in dorsal recumbency and anesthesia was induced via face mask with isoflurane. Of the 12 hens studied at age of 48 wk, 3 hens were used for immunostaining and histochemistry and 3 hens for in situ apoptosis analysis. The remaining 6 birds were used for biochemical and molecular analyses. At the age of 51 and 58 wk (21 d and 70 d after feeding treatment), 3 and surviving hens from both treatment groups, respectively, were evaluated for the presence of cardiac pathological morphologies. Ascites and pericardial effusion was diagnosed by interstitial fluid accumulation in the abdominal and pericardial cavity, respectively. Cardiac ventricle dilation was judged by ventricle distention and curvature in appearance and enlarged ventricle space in sections (Julian, 2000; Olkowski et al., 2007) .
Blood Pressure, Heart Rate, and Electrocardiography Measurement
Birds were placed in dorsal recumbency and after acclimation, light anesthesia was induced via face mask with isoflurane (at a concentration of 2%) delivered by a vaporizer with pure oxygen supply at a flow rate of one L/min. Anesthesia was then maintained with 1% isoflurane during measurements. Blood pressure was measured at the brachial artery using a portable monitor (SureSigns VM6, San Juan Capistrano, CA), a pediatric cuff bladder, and a probe following secure placement of the cuff around the distal humerus. Ultrasound gel was applied on the probe and around the elbow joint, and then the probe was taped on the articulation of the distal humerus. The cuff bladder was inflated to approximately 300 mmHg and then slowly deflated (about 3 to 5 mmHg per sec) until the pulsatile signal was recorded.
Following blood pressure measurement, positioned hens were connected to an integrated data recording device (Powerlab 15T, T15-0951, ADInstruments, New South Wales, Australia), software (Labtutor) to measure ECG using leads made with 3 alligator clips to facilitate attachment at the left and right of the sternum at the level of the thoracic inlet (Lead I) and at the anterior part of the thigh of left leg (Leads II and III). ECG patterns and heart rate were recorded for at least 30 seconds.
Histology and Fibrosis Analysis
Paraffin embedded sections from below the ventricular midline were stained with hematoxylin and eosin (H&E) to examine histology and with trichrome Masson to visualize tissue fibrosis (Histology Service of the National Chung Hsing University, Taiwan). Three sections per hen and 5 images from each section were used for chromogenic intensity quantification using Image-J software (NIH, Bethesda, MD).
Determination of Calcineurin Activity, NO Production, and DNA Content
Heart ventricles were collected, quickly cooled, minced, and portioned prior to homogenization in assay buffers. Calcineurin (known as phosphatase 2B, PP-2B) activity was determined as the removal of phosphates from the synthetic RII phosphopeptide substrate, and free phosphates were detected through colometric changes by Malachite green reaction (BML-AK816, Enzo Life Sciences, Inc. Farmingdale, NY). Nitric oxide (NO) concentrations in plasma and tissue filtrates were measured using a colorimetric test kit (Item # 780001, Cayman). Tissue filtrates were prepared from supernatants of 15% ventricle homogenates prepared in PBS, pH 7.4, and centrifuged at 100,000 × g for 30 min at 4
• C prior to ultra-filtration using a centrifugal device with a molecular weight cut-off of 10 KDa. DNA concentration was analyzed through Burton's method (Burton, 1956) .
Gene Expression by Real-time PCR Analysis
Total RNA extraction, random priming reverse transcription, and qRT-PCR amplification were conducted as described previously . Information about the primers used is given in Sup. Table S2 . Reactions were conducted in triplicate and the intra-assay coefficient of variation (CV) was less than 10%.
Western Blot Analysis
Homogenates from left ventricles were prepared in RIPA buffer and used for Western blot analysis as described . All primary antibodies were cross-reactive to chicken antigens. Rabbit anti-mouse Akt (Cat. # 9272), phospho-Akt (Ser473) (Cat. # 9271), FoxO1 (Forkhead box subfamily O1, Cat. # 9454), phospho-FoxO1 (Ser256) (Cat. # 9461), phospho-AMPKα (Thr172, 5 AMP-activated protein kinase α subunit) (Cat. # 2531), ACC-1 (acetyl-CoA carboxylase-1, Cat. # 4661S), phospho-ACC-1(Ser79) (Cat. #3661S), phospho-4E-BP1 (Thr37/46, eukaryotic translation initiation factor 4E-binding protein 1, Cat. # 9459), p38 (Cat. # 9212), phospho-p38 (Cat. # 8211), JNK (c-jun N-terminal kinase, Cat.# 9252), phospho-JNK (Cat.# 9251), and β-actin (Cat. # 4967) were used (Cell Signaling Technology, Danvers, MA). Rabbit anti-mouse AMPKα (Cat. # 07-350) and mouse anti-chicken MHC- * antibody (myosin heavy chain; cardiac muscle beta, clone 2E9) were purchased from EMD Millipore Chemicals (Billerica, MA) and Developmental Studies Hybridoma Bank (Iowa City, IA), respectively. A horseradish peroxidase-conjugated secondary antibody (Cell Signaling Technology) was used to identify the bands reactive to the primary antibodies through an enhanced chemiluminescence reagent (Pierce Biotechnology Inc., Rockford, IL).
Statistics
Data from Western blot studies that were done once at 46 or 48 wk were analyzed by one-way ANOVA. Measurements made at multiple time points were analyzed by two-way ANOVA, in which feed intake manipulation (AL or R) and duration after feeding trial (7 d, 21 d, or 70 d) were the classifying variables. Differences between group means in Western blot studies were tested by student's t test, and others were tested using Bonferroni t test when the main effect was significant. If an interaction between feed intake and duration was found, a mean comparison was performed. Values were expressed as means ± SEM. Mean differences were considered significant at P < 0.05. All statistical procedures were carried out using SPSS for Windows 13.0.
RESULTS
In contrast to R hens, AL hens exhibited a sharp, nearly 50% increase in feed intake during the first 4 d that subsequently tapered to ∼20% increased intake during d 9 to 20 (P < 0.05, Table 1, Supple. Figure S1 ). Absolute and relative liver weights of AL hens mirrored changes in feed intake, while being significantly greater than that of R hens at both 7 d (74 and 65% higher, respectively) and 21 d (35 and 23% higher, respectively); values for AL hens decreased from 7 d to 21 d in parallel with reductions in feed intake (Table 1) , with decline in relative liver weight being significant. In contrast, relative heart weight was greater (P < 0.05) in AL hens than R hens at both 7 d and 21 d, and the increase was progressive, amounting to 4.4% at 7 d and 18% at 21 d (P < 0.05, Table 1 ). Consistent with a higher protein/DNA (P < 0.05, Table 1), AL hens exhibited cardiac hypertrophy in which thickened ventricular and septal walls reduced interior dimensions. Changes were particularly notable in the left ventricle (Sup. Figure S2 ). Absolute heart weight, BW, and weight of abdominal adipose of AL hens were all significantly increased at 21 d (P < 0.05, Table 1), with body Table 1 . Feed intake, absolute and relative weights of heart, liver and abdominal adipose, cardiac protein:DNA, and egg production of broiler hens in response to restricted or unrestricted feeding. weight, abdominal adipose, and absolute heart weights increased by 10, 55, and 30%, respectively (P < 0.05).
Cardiac hypertrophic growth was verified by increased IGF-1 transcript level and downstream Akt activation (p-Akt/Akt) at 21 d in AL hens (P < 0.05, Figure 1 ; panels A and B), which in turn increased activation of FoxO1 due to Akt-mediated phosphorylation at Ser 256 of FoxO1 (P < 0.05, Figure 1 ; panel D). The Akt downstream target, translation initiation factor, 4E-BP1, also was increased in AL hens, while the transcript abundance of muscle-specific ubiquitin ligase, atrogin-1/MAFbx (muscle atrophy F box), a target gene product of FoxO proteins, was reduced (P < 0.05, Figure 2 ; panel A and B). Activation of AMPK was also suppressed consistent with downstream ACC-1 activation at 7 d and 21 d in AL hens (P < 0.05, Figures 1 and 2; panel C).
Cardiac NO production in R hens decreased progressively d 7 to d 21 while production in AL hens remained similar to one another on both d and was ∼42% higher than that of R hens on d 21 (Figure 3 , P < 0.05). Transcript levels for inducible nitric oxide synthase (iNOS) increased in AL hens d 7 to d 21 and were 120% greater than those of R hens on d 21 (Figure 3) . Heart calcineurin activity was elevated in AL hens and increased d 7 to d 21, being 42 and 83% higher than R hen activity on d 7 and d 21, respectively. This difference was accompanied by increased JNK and p38 activation at d 21 in AL hens compared to R hens (P < 0.05, Figure 3 ; panels B and C). Pathological hypertrophy in AL hens was further indicated by a progressive increase in brain natriuretic peptide (BNP) and MHC-β transcript abundance in conjunction with a significantly higher amount of MHC-β protein compared to R hens (P < 0.05, Figure 4 ).
Egg production decreased 64% while feed intake and bodyweight increased 18 and 14%, respectively, in AL hens compared to R hens following 10 wk of AL feed consumption (from age 49 to 58 wk)(P < 0.05, Sup. Table S3). In AL hens absolute and relative heart weights were 39 and 22% increased as compared to R hens (P < 0.05, Sup. Table S3 ). AL hens also exhibited a higher mortality rate, incidence of ascites, effusion in the pericardial cavity, and ventricle dilation (P < 0.05, Table 2, Figure 5 ; Panels A and B, Sup. Figure S3 ). Cardiac pathological morphologies also were observed in the 4 dead AL hens; 2 of those hens had the combination of ascites, ventricle dilation, and pericardial effusion, one developed ventricle dilation and pericardial effusion, and the fourth hen developed atrial myocardial rupture and hypertrophy ( Figure 5 ; Panels A and B). No such abnormalities were observed in the single dead R hen. In contrast to R hen counterparts, AL feeding significantly promoted cardiac fibrosis in both hens that died by sudden death and surviving hens necropsied at 70 d (P < 0.05, Figure 5 ; Panel C).
Additional cardiovascular irregularities observed in AL hens included a higher incidence of arrhythmia and persistently higher systolic blood pressure (P < 0.05, Table 3 , Supple. Figure S4 ). Irregular ECG patterns included an extreme depolarization of QR wave (Sup. Figure S4 ; panel B), a blunt QRS complex (panel C) and QR wave (panel D), an unknown depolarized ghost wave before P wave (panel E), and an overshoot of repolarization of P wave followed by an Osborne wave and unknown hyperpolarized ghost wave behind QRS complex (panel F). 
DISCUSSION
Decisions regarding management of livestock increasingly include considerations beyond production performance and, in the case of broiler chicken breeder management, include the issue of hunger due to feed restriction. However, lifting of feed restrictions markedly reduces productivity in hens while provoking obesityrelated morbidities (Chen et al., 2006; Pan et al., 2012; Walzem and Chen, 2014) . The present results show that allowing broiler hens to consume feed to appetite rapidly compromises heart health. AL feeding increased cardiac compensatory growth but maladaptively progressed towards heart failure in as few as 21 days. Indicators or pathologic change include interstitial fibrosis, suppressed AMPK activity, sustained activation of calcineurin and MAPK, and upregulation of BNP and MHC-β, hallmarks of heart failure (Catalucci et al., 2008; Maillet et al., 2013) . After 70 d AL hens showed a higher mortality and cardiac dysfunction that manifested as hypertension, ascites, ventricle dilation, pericardial effusion, and arrhythmia. These results suggest that AL feeding induces cardiac hypertrophy, which subsequently becomes pathological in response to increased workload stress due to systemic derangements and metabolic cardiomyopathies.
Cardiac hypertrophy is initiated by mechanical strength changes in the extracellular matrix, which in turn result in integrin clustering and calcium influx through transient receptor potential canonical (TRPC) channels (Catalucci et al., 2008; Maillet et al., 2013) . Mechanotransduction impulses are then transmitted as biochemical signals to induce related gene expressions in protein turnover, in which IGF-Akt signaling is best characterized as a primary pathway to regulate physiologic cardiac hypertrophy. Signaling from this pathway cascades to 4E-BP1 to increase protein translation and cardiac myocyte size (Ronnebaum and Patterson, 2010; Eijkelenboom and Burgering, 2013) . Repressive phosphorylation of FoxO by Akt suppresses expression of 2 key FoxO target gene products, atrogin-1/MAFbx and MuRF1 (muscle-specific RING finger1), 2 members of the E3 ubiquitin ligase family that targets proteins for degradation. FoxO also can be phosphorylated by AMPK at sites other than those used by Akt, leading to increased turnover and catabolism of proteins, effects that could reverse cardiac hypertrophy. AMPK acts as a metabolic switch to regulate glucose uptake and production, β-oxidation of fatty acids, and biogenesis of mitochondria. Long-term suppression of AMPK activity due to chronic excess energy availability causes pathological progression of cardiac hypertrophy, ultimately leading to heart failure, whereas intermittent AMPK activation has cardioprotective effects (Gundewar et al., 2009 ). Thus IGF-1-Akt-FoxO1 and AMPK signaling coupled with downstream 4E-BP1 and atrogin-1/MAFbx collaborate to induce cardiac hypertrophy through a net increase in protein turnover in parallel with compensatory bodyweight gain in AL hens.
The initial one-week bodyweight and fat mass gain appeared to increase cardiac workloads in such a way as to prompt mild, adaptive, reversible, and beneficial growth, i.e., physiological hypertrophy, such as might occur in pregnancy or long-term strenuous exercise (Catalucci et al., 2008; Maillet et al., 2013) . However, cardiac hypertrophy may progress maladaptively through a variety of pathological derangements such as hypertension, myocardial infarction, congenital heart defects, aortic stenosis, and metabolic cardiomyopathies (Rohini et al., 2010) . In pathological cardiac hypertrophy, a greater increase in cardiomyocyte width than length results in concentric growth leading to ventricular wall and septum thickening with a net decrease in ventricular chamber dimensions, whereas eccentric growth due to a more dramatic increase in cardiomyocyte length than width causes dilatory cardiac growth (Heineke and Molkentin, 2006; Maillet et al., 2013) . In contrast to concentric hypertrophy, eccentric growth is characterized by more severe fibrosis, myocyte death, and poor pumping function. Data from the present study support the interpretation that cardiac work overload due to systemic hypertension and metabolic derangements within heart tissue provides pathologic cues to trigger cardiac pathogenesis and ultimately leads to fibrosis, even dilation and arrhythmic ECG patterns. A particular concern is observed in the amplified Osborne waves in the QRS complex, as these are life-threatening arrhythmias . Table 2 . Blood pressure, incidence of irregular electrocardiography, rhythmicity, and heart rate of broiler hens in response to restricted or prolonged (70 d, wk 49 to 58) unrestricted feeding. Several adaptive regulators were observed during cardiac hypertrophic remodeling in AL hens including NO, calcineurin, and JNK, a stress-activated protein kinase, and p38 (Rohini et al., 2010; Takimoto, 2012; Maillet et al., 2013) . Nitric oxide acts as a critical regulator in the direction of cardiac hypertrophic remodeling through its effect on cyclic GMP (cGMP) and protein kinase G (PKG) signaling in cardiac angiogenesis, vasoconstriction/vasodilation modulation, cardiomyocyte survival, and contractility. Activation of calcineurin, a Ca2 + /calmodulin-dependent phosphatase, and downstream NFAT (nuclear factor of activated T cells) by angiotensin II, endothelin 1, and/or catecholamines mediates cardiomyocyte growth. However, sustained activation of calcineurin-NAFT pathway induces expression of hypertrophic target genes that are typically maladaptive along p38 and/or JNK activation leading to cardiomyopathy and heart failure (Takimoto, 2012; Maillet et al., 2013) .
The susceptibility of modern broilers to cardiomyopathy has been attributed to the inherent conflict between selections for higher skeletal muscle yield and coincident reductions in the relative sizes of vital organs (Wideman et al., 2013) . These tradeoffs create a high demand on cardiac output to meet nutrient and oxygen requirements by fast-growing muscle tissue despite limited size of the heart and lungs. Indeed growth selected broilers exhibit a 20 and 12% reduction of relative heart mass compared to unselected strains at the same age or at the same body mass, respectively. These congenital shifts result in anatomical limits of the cardiovascular system that compromise the bird's overall ability to accommodate high energy intakes (McGovern et al., 1999; Julian, 2000; Rance et al., 2002; Olkowski et al., 2007; Wideman et al., 2013) , which in turn facilitate mechanical and metabolic derangements systemically and within the heart itself to trigger cardiac hypertrophy as a step toward overt pathogenesis in modern broiler chickens. This is the first report of molecular mechanisms by which excess energy intake by broiler hens first causes compensatory cardiac growth and remodeling that progress into pathogenesis. Importantly, these results show that in addition to acknowledged physical disparities in body dimensions that occur with rapid growth in young broiler birds consuming feed to appetite, adult birds of stable body size experience rapid onset of chronic disease when consuming feed to appetite due to the metabolic changes that support the enormous gains in production efficiency of modern broiler strains. Interventions that are effective against cardiomyopathies in mammals might also be effective in broiler hens and allow for improved livability and production in combination with easing of feed restrictions.
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